PEPTIDES·INDEX
72 peptides412 listingsUpdated 56m agoBuild My Stack
Library

CardiogenLongevity

Khavinson peptide bioregulator studied for cardiovascular tissue.

Rating1/5SpeculativeHuman dataSafety
Compare prices — from $45.00
StatusResearch only
FDA-approvedNO
PrescriptionNO
From$45.00

Overview

Cardiogen is a synthetic tetrapeptide, alanine-glutamate-aspartate-arginine (Ala-Glu-Asp-Arg / AEDR), from Vladimir Khavinson's family of short peptide bioregulators and marketed around heart and cardiovascular tissue. Its published evidence is preclinical and comes almost entirely from the originating group: a cell-culture report that it raises cytoskeletal and nuclear-matrix protein expression in mouse fibroblasts, and review-level discussion of it as a regulator of aging-related signaling in cardiovascular cells. We found no human clinical study of Cardiogen indexed in PubMed. It is not FDA-evaluated and is sold only as a research chemical.

Related compounds

Super-HLongevityVendor research blend.NAD+LongevityCoenzyme studied for cellular energy and longevity.NAD+ / MOTS-c / 5-Amino-1MQLongevityNAD+ + MOTS-c + 5-Amino-1MQ metabolic & longevity blend.ThymogenLongevityThymus-derived dipeptide (Glu-Trp) studied for immune modulation; trialed in the US as IM862.

Sources

Starting references for the library summary. These are not dosing instructions or medical advice.

Peptide Regulation of Gene Expression: A Systematic ReviewMoleculespubmed.ncbi.nlm.nih.gov/34834147/…Tetrapeptide H-Ala-Glu-Asp-Arg-OH stimulates expression of cytoskeletal and nuclear matrix proteinsBulletin of Experimental Biology and Medicinepubmed.ncbi.nlm.nih.gov/22977870/…Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide RegulationCellspubmed.ncbi.nlm.nih.gov/36611900/…

For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.